Cargando…

Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy

Detalles Bibliográficos
Autores principales:	Holcomb, Zachary E., Santillan, Monica Rosales, Morss-Walton, Peyton C., Salian, Prerna, Her, Min Ji, Giannotti, Nicole M., Kimball, Alexa B., Porter, Martina L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329682/ https://www.ncbi.nlm.nih.gov/pubmed/32622141 http://dx.doi.org/10.1016/j.jaad.2020.06.999

Ejemplares similares

Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities
por: Morss-Walton, Peyton C., et al.
Publicado: (2022)

Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2020)

Travel burden on patients at a subspecialty hidradenitis suppurativa clinic: a single-center retrospective study
por: Kim, Diana S., et al.
Publicado: (2022)

Sunscreen recommendations for patients with skin of color in the popular press and in the dermatology clinic
por: Song, Hannah, et al.
Publicado: (2020)

COVID-19 impacts on dermatologic surgery patients: A single institution experience
por: Danesh, Melissa J., et al.
Publicado: (2021)

32688 Evaluation of demographics for patients on immunomodulatory therapy during the COVID-19 pandemic
por: Gibson, Ruby S., et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on the Delivery of Dermatological Care
por: Kimball, Alexa B., et al.
Publicado: (2022)

Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients
por: Savage, Kevin T., et al.
Publicado: (2020)

Anti-inflammatory and Immunomodulatory Effects of Antibiotics and Their Use in Dermatology
por: Pradhan, Swetalina, et al.
Publicado: (2016)

Response to: Remission of hidradenitis suppurativa after bariatric surgery
por: Golbari, Nicole Mona, et al.
Publicado: (2018)

Career satisfaction of leaders in academic dermatology: Results from a national survey,()
por: Sadeghpour, Mona, et al.
Publicado: (2019)

Immunosuppressive and immunomodulatory therapies in dermatology and coronavirus disease 2019 (COVID-19)
por: Mansouri, Parvin, et al.
Publicado: (2021)

Recommendations for COVID Vaccination for Dermatological Patients on Immunosuppressive/Immunomodulatory Therapy (IADVL Academy)
por: Munisamy, Malathi, et al.
Publicado: (2021)

Response to Letter to the Editor entitled: Rethinking biologic and pregnancy research: The importance of assessing postpartum immunosuppression of the infant
por: Gibson, Ruby S., et al.
Publicado: (2021)

Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa
por: Gibson, Ruby S., et al.
Publicado: (2022)

33892 Telehealth use at a specialty hidradenitis suppurativa clinic during the COVID-19 pandemic
por: Kim, Diana S., et al.
Publicado: (2022)

Vaccine considerations for adult dermatology patients on immunosuppressive and immunomodulatory therapies: a clinical review
por: Tan, Alice J, et al.
Publicado: (2021)

Update on biologic safety for patients with psoriasis during pregnancy
por: Porter, Martina L., et al.
Publicado: (2017)

Global dermatology talks is a virtual lecture series for equitable dissemination of dermatologic information
por: Ederaine, Sophia A., et al.
Publicado: (2022)

TNF-α inhibitors in the treatment of hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2019)

Educational Case: Necrotizing and Crescentic Glomerulonephritis With Anti-Glomerular Basement Membrane Antibodies (Anti-Gbm)
por: Peyton, Nicole, et al.
Publicado: (2020)

Impact of the COVID-19 Pandemic on Immunomodulatory and Immunosuppressive Therapies in Dermatology: Patient and Physician Attitudes in Argentina()
por: Zimman, S., et al.
Publicado: (2020)

Social media dermatologic advice: Dermatology without dermatologists
por: Trepanowski, Nicole, et al.
Publicado: (2023)

Dermatologic conditions in women receiving systemic cancer therapy [Image: see text] ()
por: Ferreira, Michelle N., et al.
Publicado: (2019)

Vaccines and dermatology: Expanding the role of dermatology clinics in the name of public health
por: Dunn, Charles, et al.
Publicado: (2022)

How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology
por: Jessica Chang, Ting Yi, et al.
Publicado: (2020)

The women behind the names: Dermatology eponyms named after women()
por: Bader, Eanas, et al.
Publicado: (2015)

The women behind the names: Dermatology eponyms named after women()()
por: Bader, Eanas, et al.
Publicado: (2017)

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
por: Cornell, Robert Frank, et al.
Publicado: (2019)

2486. The Effectiveness of High-Dose Hepatitis B Vaccination in Patients Receiving Immunomodulatory Therapy
por: Aydin, Murat, et al.
Publicado: (2018)

Immunomodulatory effect of splenectomy in lung cancer mouse xenograft models receiving radiation therapy
por: Kim, Yeeun, et al.
Publicado: (2022)

Clinical Dermatology and COVID-19 Pandemic: Narrative Review
por: Mintoff, Dillon, et al.
Publicado: (2021)

Dermatologic Surgery and Dermatologic Oncology as an Essential Part of the Modern Dermatology in Bulgaria
por: Tchernev, Georgi, et al.
Publicado: (2017)

Recurrent squamous cell carcinoma with intracranial invasion of the dura mater after Mohs surgery
por: Rosales Santillan, Monica, et al.
Publicado: (2022)

Review of applications of microneedling in dermatology
por: Iriarte, Christopher, et al.
Publicado: (2017)

The dermatological aspects of hEDS in women
por: Edimo, Cynthia O., et al.
Publicado: (2021)

DERMATOLOGY
Publicado: (1964)

DERMATOLOGY
Publicado: (1980)

Dermatology
Publicado: (1904)

Dermatology
Publicado: (1905)

Cannot write session to /tmp/vufind_sessions/sess_0v7na5h41g8fts81g7sroqg081